All Posts
China’s COVID vaccines are going global — but questions remain
5 May, 2021 | 08:32h | UTCChina’s COVID vaccines are going global — but questions remain – Nature
What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest
5 May, 2021 | 08:37h | UTC
Perspective | We may never achieve long-term global herd immunity for COVID. But if we’re all vaccinated, we’ll be safe from the worst
5 May, 2021 | 08:33h | UTCSee also: Reaching ‘Herd Immunity’ Is Unlikely in the U.S., Experts Now Believe – The New York Times (free registration required) AND We May Never Get to Herd Immunity – Think Global Health
USPSTF Draft Statement: Insufficient evidence to recommend multivitamin supplements for the prevention of CVD or cancer. The statement also recommends against the use of beta-carotene (increases risk of CVD mortality and lung cancer) or vitamin E (clear evidence of no benefit)
5 May, 2021 | 08:30h | UTCDraft Evidence Review: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer
ASCO Guideline Update: Appropriate systemic therapy dosing for obese adult patients with cancer
5 May, 2021 | 08:27h | UTC
ATS Guideline: Nucleic acid–based testing for noninfluenza viral pathogens in adults with suspected community-acquired pneumonia – Testing should be considered only in patients with severe CAP and in immunocompromised patients
5 May, 2021 | 08:28h | UTCNews Release: New clinical practice guideline on community acquired pneumonia – American Thoracic Society
M-A: Cognitive Remediation, a behavioral training–based intervention that aims to improve cognitive processes, is effective on both cognitive and functional outcomes and potentially useful for all patients with schizophrenia
5 May, 2021 | 08:19h | UTC
Pathway for enhanced recovery after spinal surgery – a systematic review of evidence for use of individual components
5 May, 2021 | 08:26h | UTCSee also: Enhanced recovery after surgery (ERAS) and its applicability for major spine surgery – Best Practice & Research Clinical Anaesthesiology AND Consensus statement for perioperative care in lumbar spinal fusion: Enhanced Recovery After Surgery (ERAS®) Society recommendations – The Spine Journal AND Enhanced Recovery After Surgery (ERAS) Society Guidelines
Commentary on Twitter (thread – click for more)
Enhanced recovery after spine surgery (ERSS) is a multi-modal and trans-disciplinary approach to achieving the best outcomes in our patients. Key components supported by data (1/2) ⬇️ #orthotwitter #neurosurgery #surgery #outcomeshttps://t.co/t4VanByVyA
— Ruwan Ratnayake MD (@ratnayakemd) April 1, 2021
Cohort study: Risk of developmental difficulties remains high among children born early
5 May, 2021 | 08:24h | UTCNeurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study – The BMJ
News release: Risk of developmental difficulties remains high among children born early – The BMJ
Commentary on Twitter
Children born preterm remain at high risk of developmental difficulties that can affect their behaviour and ability to learn, finds new research https://t.co/0A1aIQWWqk #BMJResearch
— The BMJ (@bmj_latest) May 2, 2021
RCT: Community-initiated kangaroo mother care reduced the risk of moderate-to-severe maternal postpartum depressive symptoms among mothers of low-birth-weight infants in low-income areas in India
5 May, 2021 | 08:21h | UTC
Commentary on Twitter
Skin to Skin care doesn’t only help babies; it also helps mothers!
Randomized trial of ~2k mothers from India found kangaroo care reduces postpartum depression #neoEBM #mentalhealth @JAMANetworkOpen https://t.co/6YqPQChKLe pic.twitter.com/DYAbU3Tsxu
— Abdul Razak (@DrAbdulRazak_MD) April 23, 2021
Opinion | Manual in‐line stabilization during tracheal intubation: effective protection or harmful dogma?
5 May, 2021 | 08:18h | UTC
Microscopic Colitis: A Concise Review for Clinicians
5 May, 2021 | 08:16h | UTCMicroscopic Colitis: A Concise Review for Clinicians – Mayo Clinic Proceedings
M-A: Prone positioning of nonintubated patients with Covid-19 improve oxygenation variables without any reported serious adverse events – randomized trials with patient-relevant outcomes such as the need for intubation or mortality rates are required
4 May, 2021 | 08:52h | UTCProne Positioning of Nonintubated Patients With Coronavirus Disease 2019—A Systematic Review and Meta-Analysis – Critical Care Medicine (link to abstract – $ for full-text)
Management of the Patient With Patent Foramen Ovale in 2021: A Spectrum of Cases
5 May, 2021 | 08:15h | UTC
Prior SARS-CoV-2 infection boosts response to variants after first vaccine dose
4 May, 2021 | 08:51h | UTCOriginal study: Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose – Science
Commentary on Twitter (thread – click for more)
Just published @ScienceMagazine
"After one dose, individuals with *prior infection* showed enhanced T cell immunity, antibody secreting memory B cell response to spike and neutralizing antibodies effective against B.1.1.7 and B.1.351." 👍https://t.co/7cCVM6iqdP pic.twitter.com/GiC43bjwZZ— Eric Topol (@EricTopol) April 30, 2021
WHO lists Moderna vaccine for emergency use
4 May, 2021 | 08:49h | UTCWHO lists Moderna vaccine for emergency use – World Health Organization
COVID studies note online learning stress, fewer cases in schools with protocols
4 May, 2021 | 08:47h | UTCCOVID studies note online learning stress, fewer cases in schools with protocols – CIDRAP
Study 1: COVID-19 Infections Among Students and Staff in New York City Public Schools – Pediatrics
Study 2: Household COVID-19 risk and in-person schooling – Science
Study 3: Caregiver Perceptions of Children’s Psychological Well-being During the COVID-19 Pandemic – JAMA Network Open AND Editorial: It Is Time to End the Debate Over School Reopening
WHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines
4 May, 2021 | 08:49h | UTCWHO Inches Closer to Approval of Chinese Sinopharm and Sinovac Vaccines – Health Policy Watch
[Preprint] Preventing disproportionate mortality in ICU overload situations: Empirical evidence from the first COVID-19 wave in Europe – “transferring patients proactively out of developing hotspots to less affected regions, well before high ICU workload situations emerge, will improve patient outcomes”
4 May, 2021 | 08:42h | UTC
Novel coronavirus really is seasonal, study suggests
4 May, 2021 | 08:46h | UTCNovel coronavirus really is seasonal, study suggests – LiveScience
Original study: Climate and the spread of COVID-19 – Scientific Reports
[Preprint] Frequency of neurological manifestations in COVID-19: a systematic review and meta-analysis of 350 studies – up to one-third of COVID-19 patients analyzed in this review, 89% of whom were hospitalized, experienced at least one neurological manifestation
4 May, 2021 | 08:44h | UTCCommentary: Study finds one-third of COVID-19 patients experience neurological symptoms – News Medical
M-A: In patients with atrial fibrillation, catheter ablation was associated with a 38% reduction in recurrence and a 68% reduction in hospitalizations. The rate of serious complications was 4.2% with ablation vs. 2.8% in the antiarrhythmic group, a difference that was not statistically significant.
4 May, 2021 | 08:39h | UTCAssessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials – JAMA Cardiology (free for a limited period)
ISCHEMIA trial – days alive out of hospital endpoint was higher in the conservative management group vs. invasive management group at 1 month (30.8 vs 28.4 days), 1 year (362.2 vs 355.9 days), and 2 years (718.4 vs 712.1 days)
4 May, 2021 | 08:41h | UTCComparison of Days Alive Out of Hospital With Initial Invasive vs Conservative Management: A Prespecified Analysis of the ISCHEMIA Trial – JAMA Cardiology (free for a limited period)
Original study: ISCHEMIA Trial: Health-Status Outcomes with Initial Invasive vs. Conservative Care in Stable Coronary Disease AND ISCHEMIA Trial: Initial Invasive vs. Conservative Strategy for Stable Coronary Disease AND ISCHEMIA Trial: Health Status after Invasive or Conservative Care in Coronary and Advanced Kidney Disease AND ISCHEMIA Trial: Management of Coronary Disease in Patients with Advanced Kidney Disease
Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
4 May, 2021 | 08:38h | UTCCommentary: EHRA Updates Its Popular ‘Practical’ NOAC Guide – TCTMD
Study: Most patients who develop a non-IgE-mediated hypersensitivity reaction to nafcillin can be safely treated with cefazolin
4 May, 2021 | 08:36h | UTC
Commentary on Twitter
New case series found 90% tolerated switching to cefazolin out of 80 patients who experienced non-IgE hypersensitivity reactions to nafcillin.https://t.co/YbFeWS4n4k
Our previous metas-analysis https://t.co/sJBjrx4a3r found higher odds of these reactions with nafcillin. pic.twitter.com/SIWcSuPcct— Antibiotic Tweets (@khalideljaaly) April 28, 2021